Characterization of the human intestinal CD98 promoter and its regulation by interferon-gamma

Am J Physiol Gastrointest Liver Physiol. 2007 Feb;292(2):G535-45. doi: 10.1152/ajpgi.00385.2006. Epub 2006 Oct 5.

Abstract

Growing evidence that epithelial CD98 plays an important role in intestinal inflammation focused our interest to investigate the transcriptional regulation of CD98. Our mouse-based in vivo and in vitro experiments revealed that epithelial colonic CD98 mRNA expression was transcriptionally increased in intestinal inflammation. We then isolated and characterized a 5'-flanking fragment containing the promoter region required for CD98 gene transcription. Primer extension and rapid amplification of 5'-cDNA ends were used to map a transcriptional initiation site 129 bp upstream from the translational start codon (ATG). Direct sequencing of the 5'-flanking region revealed the presence of four GC-rich stimulating protein (Sp)1 binding domains, one NF-kappaB binding domain, and no TATA box. Binding of Sp1 [Sp1(-874), SP1(-386), Sp1(-187), and Sp1(-177)] and NF-kappaB [NF-kappaB(-213)] to the promoter was confirmed by EMSA and supershift assays. Furthermore, chromatin immunoprecipitation experiments showed the in vivo DNA-Sp1 and DNA-NF-kappaB interactions under basal and IFN-gamma-stimulated conditions. Reporter genes driven by serially truncated and site-mutated CD98 promoters were used to examine basal and IFN-gamma-responsive transcription in transiently transfected Caco2-BBE cells. Our results revealed that Sp1(-187), Sp1(-177), and the NF-kappaB binding site were essential for basal and IFN-gamma-stimulated CD98 promoter activities, whereas Sp1(-874) and Sp1(-386) were not. The results from additional site-mutated CD98 promoters suggested that Sp1(-187), Sp1(-177), and the NF-kappaB site may cooperate in mediating basal and IFN-gamma-stimulated CD98 promoter activities. Finally, we demonstrated that a reduction of Sp1 or NF-kappaB expression reduced CD98 protein expression in unstimulated and IFN-gamma-stimulated Caco2-BBE cells. Collectively, these findings indicate that the Sp1 and NF-kappaB transcription factors are likely to play a significant role in IFN-gamma-mediated transcriptional regulation of CD98 in the intestinal epithelium, providing new insights into the regulation of CD98 expression in intestinal inflammation.

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Base Sequence
  • Binding Sites / genetics
  • Caco-2 Cells
  • Chromatin Immunoprecipitation
  • Colitis / genetics
  • Colitis / metabolism
  • Electrophoretic Mobility Shift Assay
  • Female
  • Fusion Regulatory Protein-1 / genetics*
  • Fusion Regulatory Protein-1 / metabolism
  • Gene Expression Regulation / drug effects*
  • Humans
  • Interferon-gamma / pharmacology*
  • Intestinal Mucosa / drug effects
  • Intestinal Mucosa / metabolism
  • Luciferases / genetics
  • Luciferases / metabolism
  • Mice
  • Mice, Inbred C57BL
  • Molecular Sequence Data
  • Mutation
  • NF-kappa B / genetics
  • NF-kappa B / metabolism
  • Promoter Regions, Genetic / genetics*
  • Protein Binding
  • RNA, Small Interfering / genetics
  • Sp1 Transcription Factor / genetics
  • Sp1 Transcription Factor / metabolism
  • Transcription Initiation Site
  • Transfection

Substances

  • Fusion Regulatory Protein-1
  • NF-kappa B
  • RNA, Small Interfering
  • Sp1 Transcription Factor
  • Interferon-gamma
  • Luciferases

Associated data

  • GENBANK/DQ125482